2025 annual financial data
Crinetics Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was -6,714.77%.
Operating income was -516,769,000 USD and net income was -465,317,000 USD.
Operating cash flow was -377,922,000 USD.
Get free Crinetics Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,696,000 USD
- Operating income
- -516,769,000 USD
- Net income
- -465,317,000 USD
- Operating cash flow
- -377,922,000 USD